Abiopharma

Veritas Capital Announces $1.1 Billion Sale of Epiq Solutions to TTM Technologies

Management and officers – staffing as of 17.8.26

H World Group Reports Strong Second-Quarter 2026 Performance and Announces New Shareholder Return Plan

Uniphore Launches Marketing AI to Usher in New Era: NYSE Content Update

Shareholders who lost money in shares of Alarum Technologies Ltd. (NASDAQ: ALAR) should contact Wolf Haldenstein Immediately

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040162 <b>Size:</b> 784 KB

Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.

Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies

Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040161 <b>Size:</b> 994 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040160 <b>Size:</b> 916 KB

Net Asset Value(s)

(10% Negative) EYEPOINT, INC. (EYPT) Announces Delay in achieved Trials for wet AMD Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040159 <b>Size:</b> 976 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023876 <b>Size:</b> 915 KB